Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04525014
Brief Title: RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors (PIRATE)

First Submitted : August 20, 2020
First Submitted that Met QC Criteria : August 21, 2020
First Posted : August 24, 2020

Last Update Submitted that Met QC Criteria : July 19, 2021
Last Update Posted : July 21, 2021